R1 RCM Inc. (NASDAQ:RCM) Receives $15.41 Consensus Target Price from Brokerages

R1 RCM Inc. (NASDAQ:RCM) has received an average rating of “Hold” from the eighteen ratings firms that are currently covering the stock, MarketBeat reports. Thirteen investment analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $15.41.

A number of research analysts have issued reports on RCM shares. Truist Financial lowered their price objective on R1 RCM from $16.00 to $14.30 and set a “hold” rating for the company in a research note on Thursday, August 8th. Cantor Fitzgerald reissued a “neutral” rating and set a $14.30 price objective on shares of R1 RCM in a research report on Tuesday, August 20th. Leerink Partnrs cut shares of R1 RCM from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 1st. Leerink Partners cut shares of R1 RCM from an “outperform” rating to a “market perform” rating and cut their price target for the company from $17.00 to $14.30 in a report on Thursday, August 1st. Finally, Canaccord Genuity Group restated a “buy” rating and issued a $15.00 price objective on shares of R1 RCM in a report on Monday, July 22nd.

Institutional Trading of R1 RCM

Large investors have recently added to or reduced their stakes in the business. Advisors Asset Management Inc. purchased a new position in shares of R1 RCM during the 1st quarter worth $27,000. Van ECK Associates Corp grew its holdings in R1 RCM by 20.5% during the fourth quarter. Van ECK Associates Corp now owns 6,141 shares of the healthcare provider’s stock valued at $65,000 after purchasing an additional 1,044 shares during the period. ANTIPODES PARTNERS Ltd purchased a new stake in R1 RCM in the second quarter worth about $86,000. QRG Capital Management Inc. bought a new position in shares of R1 RCM in the first quarter worth about $132,000. Finally, Caas Capital Management LP purchased a new position in shares of R1 RCM during the 4th quarter valued at about $148,000. 61.10% of the stock is currently owned by institutional investors.

R1 RCM Trading Up 0.1 %

RCM stock opened at $14.12 on Friday. R1 RCM has a one year low of $8.87 and a one year high of $17.17. The company has a market capitalization of $5.95 billion, a PE ratio of -176.50 and a beta of 0.84. The company’s 50 day moving average price is $13.52 and its two-hundred day moving average price is $13.00. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.84 and a current ratio of 1.84.

R1 RCM (NASDAQ:RCM) last posted its quarterly earnings data on Wednesday, August 7th. The healthcare provider reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.05) by $0.03. R1 RCM had a negative net margin of 1.68% and a negative return on equity of 1.44%. The business had revenue of $627.90 million for the quarter, compared to analyst estimates of $633.10 million. The company’s revenue was up 12.0% compared to the same quarter last year. As a group, analysts predict that R1 RCM will post -0.24 earnings per share for the current fiscal year.

About R1 RCM

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.